Archive

Eli Lilly hits $1 trillion valuation, marking a historic milestone in the pharmaceutical industry with successful weight-loss drugs.

The UK Covid-19 Inquiry reveals that 23,000 preventable deaths resulted from lockdown delays and a toxic government culture.

Explore the challenges and fiscal realities of NHI South Africa in the context of healthcare reform and political ideology.

Explore the controversy surrounding Lenacapavir in short supply in Africa and the impact on HIV prevention efforts.

China’s HIV prevention funding of $3.49 million aims to support South Africa’s young people and drug users for better health outcomes.

A pioneering public-private healthcare partnership cuts backlogs and addresses inefficiencies in surgery and patient care in KZN.

Life Healthcare share price falls 9% due to R2.9bn adjustment linked to the Piramal liability affecting investor sentiment.

Delve into the dramatic rise of childhood hypertension and its implications for future health outcomes for young people globally.

Uncover the details of the Hetero price collusion probe as the Competition Commission examines key drug procurement allegations.

Ascendis Health exits JSE following a strong investor mandate as part of its turnaround strategy aimed at unlocking value.

Hetero SA challenges the HIV drug tender decision in court, claiming exclusion from vital antiretroviral supply contracts.